SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD

Overview

SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 17 active FDA Type II Drug Master Files, covering AMBROXOL HYDROCHLORIDE; ASCORBYL GLUCOSIDE; BENIDIPINE HYDROCHLORIDE; BROENAC SODIUM; CHLORZOXAZONE; FINERENONE.

API / Drug Master Files

SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD holds 17 active (17 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ASCORBYL GLUCOSIDEActive2026-03-25
• RECOMBINANT PROTEIN A/G/LActive2026-02-12
• FINERENONEActive2026-01-26
• SUCROSE PHOSPHORYLASEActive2025-11-28
• GLYCOSYLGLYCEROLActive2025-11-28
• SUMO PROTEASEActive2025-09-22
• MENAQUINONE-4Active2024-11-25
• CHLORZOXAZONEActive2024-11-22
• LIDOCAINE HYDROCHLORIDEActive2024-11-19
• BROENAC SODIUMActive2024-11-14
• TRIBENOSIDEActive2024-11-14
• KETOROLAC TROMETHAMINEActive2024-11-13
• LEVOCARNITINEActive2024-11-11
• AMBROXOL HYDROCHLORIDEActive2024-11-11
• LIDOCAINEActive2024-11-10

Showing 15 of 17 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.